-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to research to be presented at Digestive Disease Week (DDW) 2022, patients who use cannabis require higher levels of sedation during gastroendoscopy than patients who do not use cannab.
"Patients were not aware or uncomfortable during treatment, but they did need more medication," said Yasmin Nasser, MD, the study's principal investigator and assistant professor at the Snyder Institute for Chronic Diseases at the University of Calgary's Cumming School of Medici.
We conducted a prospective cohort study of 419 adult outpatients undergoing endoscopic surgery at three Canadian cente.
Each patient completed two questionnaires, one about their marijuana use before surgery and one after surgery to indicate their awareness and comfort during surge.
Increased odds of smoking marijuana, requiring higher total sedation—defined than 5 mg of midazolam, or more than 100 mcg of fentanyl, or requiring diphenhydramine—during gastroscopy, endoscopic surgery, starting throat tubes and camer.
The study looked at whether patients smoked marijuana, but did not examine the timing, amount, or route of marijuana use prior to surgery, or whether it was inhaled, vaporized, ingested, or otherwi.
